1. Home
  2. NVAX vs ACVA Comparison

NVAX vs ACVA Comparison

Compare NVAX & ACVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVAX
  • ACVA
  • Stock Information
  • Founded
  • NVAX 1987
  • ACVA 2014
  • Country
  • NVAX United States
  • ACVA United States
  • Employees
  • NVAX N/A
  • ACVA N/A
  • Industry
  • NVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • ACVA Business Services
  • Sector
  • NVAX Health Care
  • ACVA Consumer Discretionary
  • Exchange
  • NVAX Nasdaq
  • ACVA Nasdaq
  • Market Cap
  • NVAX 1.4B
  • ACVA 1.6B
  • IPO Year
  • NVAX 1995
  • ACVA 2021
  • Fundamental
  • Price
  • NVAX $7.19
  • ACVA $5.57
  • Analyst Decision
  • NVAX Hold
  • ACVA Buy
  • Analyst Count
  • NVAX 8
  • ACVA 14
  • Target Price
  • NVAX $11.38
  • ACVA $14.65
  • AVG Volume (30 Days)
  • NVAX 4.2M
  • ACVA 5.6M
  • Earning Date
  • NVAX 11-06-2025
  • ACVA 11-05-2025
  • Dividend Yield
  • NVAX N/A
  • ACVA N/A
  • EPS Growth
  • NVAX N/A
  • ACVA N/A
  • EPS
  • NVAX 2.07
  • ACVA N/A
  • Revenue
  • NVAX $1,064,651,000.00
  • ACVA $735,475,000.00
  • Revenue This Year
  • NVAX $59.49
  • ACVA $22.90
  • Revenue Next Year
  • NVAX N/A
  • ACVA $19.07
  • P/E Ratio
  • NVAX $3.47
  • ACVA N/A
  • Revenue Growth
  • NVAX 20.27
  • ACVA 23.40
  • 52 Week Low
  • NVAX $5.01
  • ACVA $4.95
  • 52 Week High
  • NVAX $11.55
  • ACVA $23.46
  • Technical
  • Relative Strength Index (RSI)
  • NVAX 36.23
  • ACVA 24.09
  • Support Level
  • NVAX $7.08
  • ACVA $4.95
  • Resistance Level
  • NVAX $7.90
  • ACVA $5.73
  • Average True Range (ATR)
  • NVAX 0.37
  • ACVA 0.44
  • MACD
  • NVAX -0.12
  • ACVA -0.35
  • Stochastic Oscillator
  • NVAX 7.17
  • ACVA 11.83

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.

About ACVA ACV Auctions Inc.

ACV Auctions Inc is a mobile platform for wholesale car auctions. The company provides a digital marketplace for wholesale vehicle transactions and data services that offer transparent and accurate vehicle information for customers.

Share on Social Networks: